Neurotensin stimulates the sperm acrosome reaction and reduces percentages of fertilization in vitro

Genevieve E Campbell; Estella L Jones; Pierre Comizzoli; Diane M Duffy

doi:10.1016/j.xfss.2020.03.001

Neurotensin stimulates the sperm acrosome reaction and reduces percentages of fertilization in vitro

F S Sci. 2020 Aug;1(1):27-35. doi: 10.1016/j.xfss.2020.03.001. Epub 2020 Apr 8.

Authors

Genevieve E Campbell¹, Estella L Jones², Pierre Comizzoli³, Diane M Duffy⁴

Affiliations

¹ Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia.
² Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia; Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia.
³ Smithsonian Conservation Biology Institute, Front Royal, Virginia, and Washington, District of Columbia.
⁴ Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, Virginia. Electronic address: duffydm@evms.edu.

Abstract

Objective: To determine the impact of neurotensin (NTS), a naturally occurring peptide, on the function of human and nonhuman primate sperm.

Design: Experimental study.

Setting: University-based research laboratory.

Patient(s)/animal(s): Consenting normozoospermic human donors and cynomolgus macaques.

Intervention(s): None.

Main outcome measure(s): Sperm acrosome status was assessed. Computer-assisted semen analysis assessed sperm motility, progression, and velocity. Immunocytochemistry and receptor selective agonists were used to identify specific NTS receptors on sperm. Monkey oocytes were obtained after ovarian stimulation, and NTS-treated monkey sperm were used for in vitro fertilization.

Results: Neurotensin treatment of human sperm stimulated the acrosome reaction in both a dose-dependent (0.1-10 μmol/L) and time-dependent (5-30 minutes) manner. Neurotensin treatment did not alter sperm motility or progression. Both a general NTS receptor antagonist (SR142948) and a NTSR1 selective antagonist (SR48692) reduced the ability of NTS to stimulate the acrosome reaction. The neurotensin receptor NTSR1, but not NTSR2 or SORT1, was detected in monkey sperm using immunostaining. Neurotensin treatment also compromised the ability of sperm to fertilize an oocyte. Percentage of fertilization with untreated monkey sperm and monkey oocytes was 72%. Sperm pre-treated with NTS yielded a significantly lower fertilization rate of 18%.

Conclusion(s): Neurotensin effectively stimulates the acrosome reaction in human and monkey sperm. Neurotensin produced by the oviduct or cumulus cells may promote natural fertilization. Pretreatment of sperm with NTS significantly reduces fertilization. Exposure of sperm to NTS prior to reaching the oviduct has the potential for contraceptive development. Identification of NTSR1 as the mediator of NTS action provides a specific target for future studies.

Keywords: Contraception; fertility; in vitro fertilization; neurotensin; sperm acrosome reaction.

Grants and funding

P01 HD071875/HD/NICHD NIH HHS/United States